Generics Industry Faces Profitability Questions, Patent Policy Shifts

The future direction of the generic drug market is in question as the industry experiences increased competition among multiple companies all vying for the same molecule. One expert told Inside Health Policy increased competition, while good for consumers, is making drug makers rethink their place in the generics space, and some wonder whether it will lead to consolidation or increased focus on more specialty drugs. At the same time, the generic industry faces possible changes to patent settlement litigation...